Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3260560
Max Phase: Preclinical
Molecular Formula: C23H50ClN3
Molecular Weight: 367.67
Molecule Type: Small molecule
Associated Items:
ID: ALA3260560
Max Phase: Preclinical
Molecular Formula: C23H50ClN3
Molecular Weight: 367.67
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.NCCCCNCCCCNC1CCCCCCCCCCCCCC1
Standard InChI: InChI=1S/C23H49N3.ClH/c24-19-13-14-20-25-21-15-16-22-26-23-17-11-9-7-5-3-1-2-4-6-8-10-12-18-23;/h23,25-26H,1-22,24H2;1H
Standard InChI Key: QTIFYESRXOVQBM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 367.67 | Molecular Weight (Monoisotopic): 367.3926 | AlogP: 5.53 | #Rotatable Bonds: 10 |
Polar Surface Area: 50.08 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 11.24 | CX LogP: 5.60 | CX LogD: -3.06 |
Aromatic Rings: 0 | Heavy Atoms: 26 | QED Weighted: 0.45 | Np Likeness Score: 0.04 |
1. Muth A, Pandey V, Kaur N, Wason M, Baker C, Han X, Johnson TR, Altomare DA, Phanstiel O.. (2014) Synthesis and biological evaluation of antimetastatic agents predicated upon dihydromotuporamine C and its carbocyclic derivatives., 57 (10): [PMID:24784222] [10.1021/jm401906v] |
Source(1):